Home » Topics » BioWorld Science

BioWorld Science
RSS

Polymer-mediated "immunocloaking" - A new paradigm for combating transplant rejection?

Aug. 16, 2021

SARS-CoV-2 spike ectodomain protein StriFK vaccine with adjuvant reduces transmission in animals

Aug. 13, 2021

Phase I/II study of ChulaCov19 vaccine initiates at Chulalongkorn University

Aug. 13, 2021

Moderna initiates phase I/II study of mRNA-3705 in methylmalonic acidemia

Aug. 13, 2021

Nimbus and Schrödinger extend drug discovery collaboration

Aug. 13, 2021

Cogent initiates phase II study of CGT-9486 in systemic mastocytosis

Aug. 13, 2021

Sen-Jam and Duke-NUS Medical School partner to develop novel COVID-19 therapy

Aug. 13, 2021

Mustang Bio and Mayo Clinic collaborate on development of novel CAR T technology

Aug. 13, 2021

FDA clears IND application for first-in-human trial of IO-108

Aug. 13, 2021

VYNE and In4Derm enter licence agreement for discovery and development of BET inhibitor platform

Aug. 13, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...